Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ., Barrett JR., Belij-Rammerstorfer S., Sharpe H., Makinson R., Morter R., Flaxman A., Wright D., Bellamy D., Bittaye M., Dold C., Provine NM., Aboagye J., Fowler J., Silk SE., Alderson J., Aley PK., Angus B., Berrie E., Bibi S., Cicconi P., Clutterbuck EA., Chelysheva I., Folegatti PM., Fuskova M., Green CM., Jenkin D., Kerridge S., Lawrie A., Minassian AM., Moore M., Mujadidi Y., Plested E., Poulton I., Ramasamy MN., Robinson H., Song R., Snape MD., Tarrant R., Voysey M., Watson MEE., Douglas AD., Hill AVS., Gilbert SC., Pollard AJ., Lambe T., Oxford COVID Vaccine Trial Group None.

DOI

10.1038/s41591-021-01363-0

Type

Journal article

Journal

Nat Med

Publication Date

06/2021

Volume

27

Permalink Original publication